Medicines Company wins approval for blood pressure drug - Pharmaceutical Business Review
According to the company, Cleviprex, a novel intravenous antihypertensive, represents an advancement over currently available therapies, providing rapid and precise control of blood pressure in the critical care setting. Backed by comprehensive data …
